Pernicious Effect of Similar Medicinal Product’s Orphan Exclusivity: CJEU Dismisses Teva’s Appeal (C-138/15 P)
11 April 2016/
By Mayank Dixit
Mayank Dixit works in the intellectual property department of a multinational pharmaceutical company. He obtained his general Law degree from Mumbai University, India and is a registered Indian patent agent. He also holds a master’s degree in pharmaceutical sciences from Institute of Chemical Technology (ICT), Mumbai.